Davis Polk advised Morgan Stanley, the representative of the several underwriters in the transaction. The transaction consisted of a $700 million SEC-registered offering of 5,923,670 common shares...
Chart Industries’ $1.1 Billion Common and Depositary Share Offerings
FREYR Battery’s $264.5 Million Debut Public Share Offering
Davis Polk advised the underwriters in the offering. FREYR Battery announced the $264.5 million debut registered equity offering of 23,000,000 of its ordinary shares, which includes the full...
Indie Semiconductor’s $160 Million Convertible Senior Notes Offering
O’Melveny & Myers advised indie Semiconductor, while Davis Polk advised the representative of the initial purchasers in the offering. indie Semiconductor, Inc. executed its offering of $160...
Wolfspeed’s $1,525 Million Convertible Senior Notes Offering
Latham & Watkins represented Wolfspeed, while Davis Polk advised the representatives of the initial purchasers in the offering. Wolfspeed, Inc. (NYSE: WOLF), a global leader in Silicon...
Qualcomm’s $1.9 Billion Notes Offering
Cravath represented QUALCOMM Incorporated, while Davis Polk advised the representatives of the several underwriters in the offering. Qualcomm Incorporated executed its SEC-registered offering of $700 million aggregate...
Roivant Sciences’ $150 Million Equity Offering
Davis Polk advised Roivant Sciences Ltd. in the deal, while Covington represented the underwriter, Cantor Fitzgerald. Roivant Sciences Ltd. announced its debut SEC-registered offering of 30,000,000...
European Biotech Acquisition’s $200 Million Combination With Oculis
Davis Polk advised European Biotech Acquisition Corp. on the deal while Cooley and Vischer represented Oculis. European Biotech Acquisition Corp. (EBAC), a SPAC, signed its $200 million...
MarketWise’s Warrant Exchange Offer
Davis Polk advised BofA Securities, the dealer manager and solicitation agent in the transaction. MarketWise, Inc. announced an offer to exchange outstanding warrants to purchase shares of...
Gamida Cell’s $20 Million Shares Offering
Davis Polk advised the representative of the underwriters in the offering. Gamida Cell Ltd. announced the $20 million SEC-registered follow-on offering of 12,905,000 ordinary shares. The ordinary shares...
Roivant Sciences’ $400 Million At-The-Market Offering
Davis Polk advised Roivant Sciences Ltd. in the offering. Roivant Sciences Ltd. announced its at-the-market offering program under which Roivant may issue and sell its common shares...
Perella Weinberg Partners’ Warrant Exchange Offer
Davis Polk advised the dealer manager and solicitation agent in the transaction. The transaction consisted in an offer to exchange outstanding warrants to purchase shares of...
Covalto’s Business Combination With LIV Capital Acquisition Corp. II
Simpson Thacher & Bartlett LLP advised Covalto on the deal. Davis Polk & Wardwell LLP represented LIV Capital Acquisition Corp. II in the transaction. Covalto Ltd. announced...